Investor Presentaiton slide image

Investor Presentaiton

FURTHER INVESTMENT IN Science and IP COMVITA LABORATORIES Est. 1974 Industry Leading in Clinical Trials Mānuka honey for Digestive Health (HVN National Science Challenge grant awarded: $875K) More Scientific Patents Granted 5 Patents Granted in FY22 To date 12 Patents Filed & 5 Granted $1.3M 12 Industry Leading Lab Testing Standards 392,469 Lab Results in FY22 (FY21: 246,804) +59% VS. PCP Leading Scientific & Clinical Expertise Backed by Expert Global Advisory Board AU, NZ, USA, UK, CHN 8 Members World-Leading Quality 23 Independent Audits and Certifications Incl. BRC "AA", IANZ, MPI Recognised Lab, MPI Transitional Facility #1 Greater Investment in Consumer Health Skin & Gut Health Mānuka for Atopic Dermatitis & Digestive Health Propolis for Immunity $1.2M $5.7M R&D spend qualifying for RDTI: Consumer Health $1.2M, Supply and Process Improvement $4.5M 5 patents granted (3 in the same patent family) and 12 patents filed (10 in the same patent family) COMVITA INVESTOR PRESENTATION FULL YEAR RESULT FY22 17
View entire presentation